CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML

NCT03384225 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

High Risk Acute Myeloid Leukemia
Allogeneic Hematopoeitic Stem Cell Transplantation

Interventions

DRUG: Cladribine
DRUG: Fludarabine
DRUG: Busulfan
DRUG: Cytarabine

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]